A detailed history of Clari Vest Asset Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 73,967 shares of CPRX stock, worth $1.13 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
73,967
Previous 73,829 0.19%
Holding current value
$1.13 Million
Previous $1.24 Million 5.0%
% of portfolio
0.12%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$13.18 - $17.11 $1,818 - $2,361
138 Added 0.19%
73,967 $1.18 Million
Q4 2023

Feb 13, 2024

SELL
$11.78 - $17.29 $156,297 - $229,403
-13,268 Reduced 15.23%
73,829 $1.24 Million
Q2 2023

Aug 14, 2023

BUY
$11.5 - $18.08 $181,355 - $285,121
15,770 Added 22.11%
87,097 $1.17 Million
Q1 2023

May 08, 2023

SELL
$14.34 - $21.05 $1,046 - $1,536
-73 Reduced 0.1%
71,327 $1.18 Million
Q4 2022

Feb 14, 2023

SELL
$12.25 - $19.5 $12,250 - $19,500
-1,000 Reduced 1.38%
71,400 $1.33 Million
Q1 2022

May 04, 2022

BUY
$5.31 - $8.31 $384,444 - $601,644
72,400 New
72,400 $601,000
Q2 2021

Aug 09, 2021

SELL
$4.29 - $6.05 $589,446 - $831,270
-137,400 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$3.45 - $4.69 $26,220 - $35,644
7,600 Added 5.86%
137,400 $634,000
Q4 2020

Feb 09, 2021

SELL
$2.97 - $3.83 $5,346 - $6,894
-1,800 Reduced 1.37%
129,800 $434,000
Q3 2020

Nov 09, 2020

SELL
$2.97 - $5.08 $23,760 - $40,640
-8,000 Reduced 5.73%
131,600 $391,000
Q2 2020

Aug 12, 2020

SELL
$3.48 - $5.05 $28,188 - $40,905
-8,100 Reduced 5.48%
139,600 $645,000
Q1 2020

May 04, 2020

SELL
$2.61 - $5.21 $24,273 - $48,453
-9,300 Reduced 5.92%
147,700 $569,000
Q4 2019

Feb 12, 2020

SELL
$3.67 - $5.7 $6,239 - $9,690
-1,700 Reduced 1.07%
157,000 $588,000
Q2 2019

Aug 16, 2019

BUY
$2.7 - $6.11 $428,490 - $969,657
158,700 New
158,700 $610,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $1.57B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.